In our study, we demonstrated that CD27+IgD+ NSw MBCs exhibit the most pronounced inhibitory phenotype among all MBCs in aggressive HCC/CaMIN, characterized by elevated levels of PD-L1 and IL-10 expression. The gene discussed is CD27; the disease is hepatocellular carcinoma.